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Abstract
Objective Weight loss interventions have produced little
change in insulin sensitivity in black women, but mean data
may obscure metabolic benefit to some and adverse effects for
others. Accordingly, we analyzed insulin sensitivity relative to
fat mass change following a weight loss program.
Design and Methods Fifty-four black women (BMI range
25.9 to 54.7 kg/m2) completed the 6-month program that
included nutrition information and worksite exercise facilities.
Fat mass was measured by dual-energy X-ray absorptiometry,
and insulin sensitivity index (SI) was calculated from an
insulin-modified intravenous glucose tolerance test using the
minimal model.
Results Baseline SI (range 0.74 to 7.58 l/mU
−1•min−1) was
inversely associated with fat mass (r= −0.516, p<0.001), inde-
pendent of age. On average, subjects lost fat mass (baseline
40.8±12.4 to 39.4±12.6 kg [mean±SD], P<0.01), but 17
women (32 %) actually gained fat mass. SI for the group was
unchanged (baseline 3.3±1.7 to 3.2±1.6, P=0.67). However,
the tertile with greatest fat mass loss (−3.6 kg, range −10.7 to
−1.7 kg) improved insulin sensitivity (SI +0.3±1.2), whereas
the tertile with net fat mass gain (+0.9 kg, range −0.1 to +
3.8 kg) had reduced insulin sensitivity (SI −0.7±1.3) from
baseline values (P<0.05 by ANOVA).
Conclusions Black women in a weight loss program who lose
fat mass may have improved insulin sensitivity, but fat mass
gain with diminished sensitivity is common. Additional sup-
port for participants who fail to achieve fat mass loss early in
an intervention may be required for success.
Keywords Obesity . insulin sensitivity . women . race .
intervention
Introduction
The obesity epidemic has steadily worsened as nearly 70 % of
adults in the USA are at least overweight and more than one-
third are obese [1, 2]. The prevalence of obesity is the highest
among underrepresented minority populations, particularly
blacks who have the highest age-adjusted rate of obesity na-
tionwide [1, 2]. Additionally, blacks also have a disproportion-
ately high prevalence of type 2 diabetes and are at greater risk of
developing associated cardiovascular complications including
coronary artery disease, myocardial infarction, stroke, conges-
tive heart failure, and peripheral vascular disease [3–6].
Major contributors to the growing obesity epidemic are
inactivity and excess energy intake [7]. Evidence suggests
that the work place contributes to the prevalence of obesity
as employees in the USA are sedentary for large portions of
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the workday [7, 8]. To counter the mounting obesity rates,
many organizations have initiated wellness programs at the
work site to achieve weight loss by encouraging exercise and
reduced caloric intake [9–14]. While many of these programs
have been effective in promoting weight loss and improving
health measures among whites, black women have been less
successful in achieving these ends [15]. Therefore, we hy-
pothesized that an intervention at the worksite that provides
women with healthful information, either through interactive
group sessions or internet-based tools, as well as exercise
resources in the work place would enable fat mass loss and
improve insulin-mediated glucose metabolism in overweight
and obese black women. Specifically, we proposed that this
decrease in fat mass would improve insulin sensitivity for
those women who completed the diet and exercise program.
Methods and Procedures
Study population Overweight (body mass index [BMI] 25 to
<30 kg/m2) and obese (BMI≥30 kg/m2) nondiabetic (fasting
glucose <126 mg/dL) black (by self-report) female employees
of the National Institutes of Health (NIH), Bethesda, Mary-
land were enrolled. Participants were recruited by flyers dis-
tributed across the Bethesda campus of NIH and self-
identified as healthy without participation in structured exer-
cise or weight loss programs and weight stable (fluctuation in
weight < 5 %) over the previous 3 months. Women were
excluded from participation if screening blood work revealed
anemia (hemoglobin <11 g/dL), liver, kidney, or thyroid dis-
ease. Prescription medications at stable doses for at least
2 months – including hormonal preparations for thyroid dys-
function or estrogen preparations (i.e., birth control or post-
menopausal hormone therapy) – were permitted, but a change
in medications during the study was prespecified as an exclu-
sion criterion from further participation due to the potential of
confounding main outcome measures. The protocol was ap-
proved by the Institutional Review Board of the National
Heart Lung and Blood (NHLBI) and registered in www.
ClinicalTrials.gov (NCT00666172) prior to study initiation.
All subjects provided informed consent.
Study Design All participants were provided internet-based
nutrition and exercise information created by NHLBI for
employees (recent version can be found at http://apps.nhlbi.
nih.gov/keepthebeat) that included recommendations from the
Department of Health and Human Services and the US
Department of Agriculture [16]. The web site included
walking paths around the NIH Bethesda campus, sample
menus, healthful lifestyle information, and tools for counting
calories. Each participant was given a pedometer (Walk4Life,
Plainfield, IL) with instructions to increase average daily step
count by 5,000 steps over their baseline average and given
card-key access to private fitness rooms located in three
buildings on campus, each equipped with aerobic exercise
equipment (e.g., treadmill, elliptical machine, and supine bi-
cycle). Participants were also encouraged to continue physical
activity – especially walking – on nonwork days. Enrollees
were randomized into either intervention or control groups:
Intervention participants attended nutrition education sessions
(weekly for the first 3 months, monthly for the last 3 months)
conducted by a registered dietitian, whereas control subjects
were not provided this instruction. Subjects were compensat-
ed for their time and inconvenience of testing.
Testing All tests were performed at the NIH Clinical Center,
Bethesda, Maryland at baseline and at 6 months following an
overnight fast. Premenopausal women were scheduled for
testing within the first 10 days of their menstrual cycle. Base-
line and 6 month visits included collection and review of 3-
day food records by the registered dietitians. The food records,
which included two work days and one nonwork day, were
reviewed for accuracy by dietitians and then analyzed using
the Nutrition Data System for Research (NDS-R versions
2009–2011, Minneapolis, MN) [17].
Body weight (to the nearest 0.1 kg, Scale-Tronix 5702,
Carol Stream, IL) and height (by stadiometry to the nearest
0.1 cm, Seca 242, Hanover, MD) were measured in light-
weight clothing. Body fat (%) and truncal fat (%) were mea-
sured by dual-energy X-ray absorptiometry (DXA; iDXA
Software Encore 11.10, GE Lunar Medical Systems, Madi-
son, WI). Fat mass (kg) and % truncal fat mass were calculat-
ed using the bodyweight and DXA measurements. Exercise
performance was measured during a graded treadmill exercise
test [18] with a SensorMedics Vmax Spectra 229c metabolic
cart (CareFusion, San Diego, CA) for the analysis of oxygen
consumption at peak exercise (VO2 peak). In addition, women
were asked to record daily pedometer counts and track the
amount of time walking and using aerobic exercise machines
each day throughout the 6-month study. Activity diaries were
submitted on a weekly basis.
A reduced sample insulin-modified intravenous glucose
tolerance test (FSIGT) was used in conjunction with the
minimal model of glucose kinetics to determine an insulin
sensitivity index (SI) (MinMOD Millenium v6.02, Los
Angeles, CA) [19, 20]. Testing was performed at 8 AM fol-
lowing a 12-h fast after placement of intravenous lines in both
antecubital veins. After obtaining baseline glucose and insulin
samples, dextrose (0.3 g/kg) was injected at time 0 over
approximately1 min. A bolus of insulin (0.03 units/kg) was
injected rapidly at 20 min. Blood samples were taken for
determination of glucose and insulin concentrations at 0, 2,
4, 8, 19, 22, 30, 40, 50, 70, 100, and 180 min. The acute
insulin response to glucose (AIRg) was determined by the
area under the insulin concentration curve above basal insulin
concentration between 0 and 10 min.
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Leptin was measured in serum by ELISA (Millipore, Bil-
lerica, MA). The minimum detectable concentration was
0.5 ng/ml, with intraassay CV 3.7 % and interassay CV
4.0 %. Adiponectin was measured in serum by ELISA
(R&D Systems, Minneapolis, MN). The minimum detectable
concentration was 0.25 ng/ml, with intraassay CV 3.5 % and
interassay CV 6.5 %.
One hundred forty-one black women were assessed for
eligibility in this protocol, and 114 were enrolled for partici-
pation (Fig. 1). Of the 114 participants who underwent base-
line testing, 28 women were excluded from analysis due to
failed baseline or follow-up FSIGT. Reasons for failed
FSIGT’s included hemolyzed samples (n=21), inability to
place intravenous lines in antecubital veins of both arms (n=
4), improper testing technique (n=2), and poor data fit for
predicted glucose disposal (n=1). In addition, 32 women
withdrew from the study prior to completing 6 months partic-
ipation. Thus, 54 subjects underwent testing for fat mass and
insulin sensitivity at baseline and at 6 months. To evaluate
whether the characteristics of these 54 subjects differed from
the remaining subjects who either had incomplete data or
dropped out of the study (Fig. 1), we compared all baseline
variables. The two groups did not differ in age or baseline
BMI, total fat mass, % truncal fat mass, insulin, glucose, or SI
(all P>0.1). Those that dropped out or with incomplete data,
however, had significantly lower baseline VO2 peak than
those who completed the study (20.7±4.4 vs. 22.8±4.9 mL
O2/kg/min, P=0.019).
Statistical Analysis As it was anticipated that not all subjects
would lose weight and fat mass, it was planned that changes in
insulin sensitivity would be analyzed for those who lost the
most fat mass compared with those who did not lose fat mass.
Accordingly, the primary analysis for this report was change in
insulin sensitivity by tertile of change in fat mass for women
who had measures both at baseline and at 6-month completion
of the protocol by analysis of variance (ANOVA) with posthoc
testing among tertiles, if statistically significant. Since no sig-
nificant difference was determined in weight loss (−2.1±3.5 kg
vs. −1.1±3.9 kg, P=0.167) following program completion
between those subjects randomized to attend group nutrition
instructional sessions (n=26) and those who were provided
internet-based nutrition and exercise information only (n=28),
the groups were combined for this analysis. The contribution of
exercise performance to insulin sensitivity at baseline and fol-
lowing program completion was also investigated. Paired or
unpaired t-tests for continuous data and chi-square proportion-
ality tests were performed using InStat biostatistics software
(Version 3.06, 2003). Univariate associations among fat mass
measurements, adipokines, exercise performance, and insulin
sensitivity were performed using either Pearson’s correlation or
Spearman’s rank correlation, as appropriate. Independent pre-
dictors of change in SI following program completion were
determined by multivariable regression analysis. All adjusted
model analyses were performed using the SAS statistical anal-
ysis package (SAS User’s Guide: Statistics, Version 9 Edition:
SAS Institute Inc, Cary, NC). Skewed data were log trans-
formed. A P-value ≤0.05 was considered statistically signifi-
cant. Nonskewed data are reported as mean±standard devia-
tion. Tertiles of fat mass change are reported as mean and range
of values within each tertile.
Results
For the 54 subjects included in the analysis for this report, the
average age at baseline was 45±10 years with an average BMI
of 34.2±6.0 kg/m2 (range 25.9 to 54.7 kg/m2); 70 % had a
BMI≥30 kg/m2. Menopausal status of the subjects was 37
premenopausal [five on hormonal contraception therapy
(14 %)], 17 perimenopausal, or postmenopausal [two on
hormonal therapy (12 %)]. Energy intake for the group at
baseline was 2,024±614 kcal/day. Baseline measures of fat
mass, exercise performance, insulin sensitivity, and
adipokines leptin and adiponectin are shown in Table 1.
At baseline, SI for the 54 subjects ranged from 0.74 to
7.58 L•mU−1•min−1 and was inversely associated with total
and % truncal fat masses when adjusted for age (Fig. 2).
Additionally, SI was positively associated with exercise per-
formance by VO2 peak at baseline (r=0.448, P<0.001). Lep-
tin was positively associated with total fat mass (r=0.652,
P<0.001) and % truncal fat mass (r=0.643, P<0.001), and
inversely associated with SI (r= −0.492, P<0.001).
Adiponectin levels, however, were not related to baseline fat
mass (either total or % truncal) or SI (all P>0.208). Endoge-
nous insulin response, AIRg, was positively associated with
total fat mass (r=0.310, P=0.024) but not with % truncal fat
mass (P=0.200).
At program completion, reduction in energy intake (−339±
653 kcal/day P<0.001) was determined for the group, based
on analyses of baseline and 6-month 3-day food records. On
average, subjects reported the following activity measures:
time devoted to daily walking 20±24 min/day and to aerobic
exercise 8±8 min/day, with pedometer counts 6,131±3,596
steps/day. Six-month measures of weight, fat mass, exercise
performance, insulin sensitivity, and adipokine levels are
shown in Table 1. Significant reductions in weight (−1.6±
3.7 kg, range −11.6 to +5.5 kg; P<0.01), total fat mass (−1.4±
2.8 kg, range −10.7 to +3.8 kg; P<0.01) and % truncal mass
(−1.1±2.7 kg, range −10.9 to +3.4 kg P<0.01), improvement
in VO2 peak (+1.0±3.1 mLO2/kg/min, range +9.6 to −4.1 mL
O2/kg/min; P<0.001) and reduction in leptin levels (−9.1±
27.2 ng/mL, range −116.6 to +50.2 ng/mL; P<0.001) were
determined for subjects at 6 months. Improvement in SI from
baseline to 6-month follow-up was significantly associated
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with reductions in both total FM (r= −0.348, P=0.010) and %
truncal FM (r= −0.423, P=0.001). There was no association
between the change in VO2 peak and change in SI. Reduction
in % truncal fat mass was associated with reduction in leptin
(r=0.381, P=0.008). Reduction in leptin was associated with
improvement in SI (r= −0.337, P=0.021). Change in AIRg
showed a trend toward significance with the change in total fat
mass (r=0.238,P=0.087) but not with the change in% truncal
fat mass (P=0.135) following completion of the program.
Although on average subjects lost total fat mass and %
truncal fat mass, 17 women (32 %) actually gained fat mass
despite reporting energy intake reduction (−483±697 vs.
−287±623 kcal/day), time devoted to daily walking (27±25
vs. 17±24 min) and aerobic exercise (7±5 vs. 9±10 min), and
pedometer counts (5,574±2,891 vs. 6,394±3,895 steps/day)
similar to the 37 who lost fat mass (all P>0.2). Weight gain
was observed with similar frequency among women who
were overweight (4 of 16) or obese (11 of 38, P=0.729) at
the beginning of the program. There was a trend toward
fewer women experiencing weight gain in the group
randomized to attend nutrition instructional sessions (4
of 26) vs. those who were provided internet-based nu-
trition and exercise information only (11 of 28, P=
0.098). When participants were analyzed by tertiles of
fat mass change and % truncal fat mass change, the
tertile with the greatest fat mass loss improved insulin
sensitivity in contrast to the tertile with net fat mass gain
in which SI worsened (Fig. 3). By multivariable
Fig. 1 Flow chart of participant
participation
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regression analysis, changes in either total fat mass (β=
−0.038, P=0.039) or % truncal fat mass (β= −0.047, P=
0.019) were independent predictors of change in SI, after
adjustment for age, change in leptin, and change in VO2
peak.
To help identify possible indicators of change in fat mass
following program participation, subject characteristics of
the tertile with the greatest fat mass loss were compared
to the tertile with net fat mass gain. There were no
significant differences between the two groups in age
or baseline weight, BMI, hormonal status (premenopaus-
al, perimenopausal, or postmenopausal), total fat mass,
% truncal fat mass, VO2 peak, adipokine levels, glucose
and insulin levels, SI, or AIRg (all P>0.2). Although
the women in the tertile with the greatest fat mass loss
had a slightly greater proportion of participants in the
intervention group with dietitian-led classes vs. the
tertile with net fat mass gain (61 vs. 44 %), this did
not achieve statistical significance (P=0.317).
Table 1 Data for 54 overweight and obese black women who completed
the 6-month weight loss program
Baseline 6 months P-value
Adipositya
Weight (kg) 92.6±18.1 91.1±18.9 0.003
Total fat mass (kg) 40.8±12.4 39.4±12.6 <0.001
% Truncal fat mass (%) 46.4±6.6 45.2±6.7 0.003
Exercise performancea
Peak VO2 (mL/kg/min) 22.8±4.9 23.8±5.3 0.028
Adipokinesa
Leptin (ng/ml) 61.1±37.1 52.1±24.2 0.027
Adiponectin (μg/ml) 5.6±3.6 5.7±2.9 0.389
Insulin sensitivitya
Insulin (μU/ml) 7.2±5.4 6.9±6.4 0.077
Glucose (μU/ml) 91±9 88±10 0.060
Insulin sensitivity index (SI) 3.30±1.71 3.21±1.56 0.665
AIRg 529±461 548±455 0.335
aValues represented as mean±SD
Fig. 2 Baseline correlations
between insulin sensitivity index
and total fat mass (top) and %
truncal fat mass (bottom), adjusted
for age
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Discussion
Our principal finding was that fat mass loss through partici-
pation in a worksite weight loss program can significantly
improve insulin sensitivity (increase in SI) in overweight and
obese nondiabetic black women. By multivariable regression
analysis, fat mass loss – both total and truncal – was a
significant predictor of increase in SI, independent of changes
in leptin or improvement in exercise performance, both of
which have been shown to improve insulin sensitivity
[21–23]. We found no evidence of improved insulin
secretion with fat mass loss as no difference was ob-
served in the AIRg in the initial minutes of the FSIGT
between the tertile of subjects with the greatest fat mass
loss compared to the tertile with net fat mass gain. Our
findings of improved insulin sensitivity with relatively
modest fat mass reduction extend observations in other
studies which have enrolled blacks that reported
improved insulin sensitivity but with greater weight loss
than achieved by most of our participants [24–26].
A disconcerting finding in our study was that nearly one-
third of the overweight and obese black subjects who
underwent testing for fat mass and insulin sensitivity at base-
line and at 6 months actually gained fat mass with associated
adverse metabolic consequences. Specifically, a decrease in
insulin sensitivity was observed in the tertile of women with
net fat mass gain despite self-reports of reduced caloric intake
and increased physical activity similar to that of the tertile who
lost the most fat mass. One reason why some of the partici-
pants gained fat mass over the course of this study despite
provision of resources to enable weight loss could be loss of
interest in the program. As reviewed by Fitzgibbons et al. [15],
weight loss trials – including those with black women – often
have high attrition similar to the nearly 30 % dropout rate
observed in our study. However, the participants we report in
this paper – including those who gained fat mass – all
Fig. 3 Tertiles of change in total
(upper panel) and percent truncal
fat mass (lower panel) and change
in insulin sensitivity after
completion of the 6-month weight
loss program
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completed the 6-month program, suggesting commitment to
the goals of the study. An alternative explanation for fat mass
gain by many subjects in our study may be misinterpretation
of the energy expenditure associated with physical activity
performed by participants. Although all participants were
provided with the same fitness resources including access to
exercise rooms at the worksite and pedometers to incentivize
exercise, those who lost fat mass had significantly greater
improvement in exercise performance despite reporting simi-
lar time spent in daily aerobic activity and pedometer counts to
those who gained fat mass. It is possible that those who gained
fat mass either engaged in physical activity with lower energy
expenditure compared with those who lost fat mass or in-
creased caloric intake as a result of over-overestimating calo-
ries consumed with relatively low-intensity exercise. Addi-
tionally, errors in assessing – and reporting – nutritional com-
position of diet and daily caloric intakemay have also played a
role in the increased fat mass experienced by several of our
participants. It is possible that the 3-day food records used at
the beginning and end of each participant’s participationmight
not have been indicative of energy intake throughout the 6-
month period. Use ofmore reliable food assessment tools such
as the picture recording technique reported by Six et al. [27]
may limit the discrepancy between the foods consumed and
those reported in weight loss studies similar to ours [28].
Regardless of the reason for fat mass gain by some of our
subjects, the metabolic consequence was apparent in the form
of reduction in insulin sensitivity. Baseline characteristics of
our participants did not identify who would lose fat mass and
improve insulin sensitivity and who would gain fat mass with
diminished insulin sensitivity at completion of the program.
More detailed phenotyping of novel adipokines and other
biomarkers involved in regulation of body weight in future
work may identify mechanisms by which study participants
may have been resistant to fat mass loss, as has been seen in
studies of weight regain [29].
Our findings of fat mass gain with reduced insulin sensi-
tivity in almost a third of participants indicate that some may
require additional attention to achieve weight and fat mass
loss. One approach that has been proposed to identify and
focus on those participants that are motivated to lose weight
but are not successfully doing so is a stepped-care design [30,
31]. In a stepped-care intervention, participants that are not
attaining short-term weight loss goals are prescribed addition-
al resources and nutrition counseling to help them achieve
their long-termweight loss goals. Thus, Jakicic and colleagues
[31] tested a stepped-care model in a randomized trial of 363
overweight and obese adults (83 % female, 33 % nonwhite)
that included increased contact frequency (group sessions,
mail, telephone, and individual sessions) and even meal re-
placements for participants missing weight loss goals at 3-
month intervals. This intervention approach resulted in ap-
proximately 7 % weight loss after 18 months of participation.
It is possible that fat mass loss may be achieved by the use of
portable devices to self-monitor diet and physical activity as
reported in the Move! Trial conducted in a Veterans Admin-
istration cohort [32]. In addition, individualized counseling or
motivational interviewing might have increased compliance
and achieved greater success in our participants [33].
An important message of this study is the demonstration
that relatively modest fat mass loss achieved by most black
women improved insulin sensitivity in a population that is at
high risk of developing diabetes and associated complications.
A limitation of the study is that the duration was only
6 months: Continuation for a longer period might have result-
ed in greater fat mass loss and further improvement in insulin
sensitivity but might have been associated with even greater
weight and fat mass gain with worsened metabolic conse-
quences in some participants. In addition, as this report eval-
uates the change in fat mass and insulin sensitivity only in
overweight and obese black women, these findings cannot be
extended to men or to other racial groups.
We conclude that fat mass loss can be achieved in over-
weight and obese nondiabetic black women through partici-
pation in a worksite weight loss program, which can signifi-
cantly improve insulin sensitivity. However, fat mass gain and
worsened insulin sensitivity were also frequent among our
participants despite self-reports of compliance. As a result,
participation by black women in weight loss programs could
paradoxically contribute to diabetes risk in some subjects,
who may require special attention early in these programs to
achieve success.
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